Why does pharma still make drugs using a slow, batch-based process?

Why does pharma still make drugs using a slow, batch-based process?

What to read around the web today

• I’m 26. Coronavirus sent me to the hospital. New York Times
• Underpromise, overdeliver. Science
• Covid-19 and the stiff upper lip — the pandemic response in the United Kingdom. New England Journal of Medicine
• Women rival men in scientific research publications and citations, but short careers set them back. Nature Index
• Despite investments and advocacy, pharma’s still making its drugs in batches that can take months — rather than continuously. Why? STAT Plus